Antimalarial Drug Quinacrine Binds to C-Terminal Helix of Cellular Prion Protein

Journal of Medicinal Chemistry
2003.0

Abstract

Using NMR spectroscopy we show that the cellular prion protein constitutes a target for binding of various acridine and phenothiazine derivatives. We unambiguously map the quinacrine binding site of recombinant human prion protein to residues Tyr225, Tyr226, and Gln227 of helix alpha3, which is located near the "protein X" epitope. The millimolar dissociation constant of the complex suggests that in vivo inhibition of prion propagation occurs after 10000-fold concentration of quinacrine within endolysosomes.

Knowledge Graph

Similar Paper

Antimalarial Drug Quinacrine Binds to C-Terminal Helix of Cellular Prion Protein
Journal of Medicinal Chemistry 2003.0
Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position
European Journal of Medicinal Chemistry 2011.0
A Chimeric Ligand Approach Leading to Potent Antiprion Active Acridine Derivatives:  Design, Synthesis, and Biological Investigations
Journal of Medicinal Chemistry 2006.0
Similar Structure−Activity Relationships of Quinoline Derivatives for Antiprion and Antimalarial Effects
Journal of Medicinal Chemistry 2006.0
Antiprion activity of functionalized 9-aminoacridines related to quinacrine
Bioorganic & Medicinal Chemistry 2008.0
Selective plasma protein binding of antimalarial drugs to α1-acid glycoprotein
Bioorganic & Medicinal Chemistry 2008.0
Structure–activity relationship study of 9-aminoacridine compounds in scrapie-infected neuroblastoma cells
Bioorganic & Medicinal Chemistry Letters 2006.0
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer’s and Prion Diseases
ACS Medicinal Chemistry Letters 2013.0
New Series of Antiprion Compounds:  Pyrazolone Derivatives Have the Potent Activity of Inhibiting Protease-Resistant Prion Protein Accumulation
Journal of Medicinal Chemistry 2007.0
Huprine–Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer’s and Prion Diseases
Journal of Medicinal Chemistry 2012.0